The Biotech Renaissance: How AI and M&A Are Igniting a Sector-Wide Recovery
The biotechnology sector, having endured a grueling multiyear "winter" characterized by high interest rates, funding droughts, and regulatory skepticism, has...
The biotechnology sector, having endured a grueling multiyear "winter" characterized by high interest rates, funding droughts, and regulatory skepticism, has...